Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis

por Migliore, Alberto, Integlia, Davide, Pompilio, Giuseppe, Di Giuseppe, Francesca, Aru, Cinzia, Brown, Tray
Publicado 2019

A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart...

por Ward, Thomas, Lewis, Ruth D., Brown, Tray, Baxter, Garth, de Arellano, Antonio Ramirez
Publicado 2023

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Pati...

por Khair, Andrew, Brown, Tray, Markert, Marie, Barsøe, Carsten Rødseth, Daftary, Gaurang S., Heiser, Patrick W.
Publicado 2023

The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland

por Ward, Thomas, Brown, Tray, Lewis, Ruth D., Kliess, Melodi Kosaner, de Arellano, Antonio Ramirez, Quinn, Carol M.
Publicado 2022